Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
54.3M
-
Shares change
-
+3.61M
-
Total reported value, excl. options
-
$3.23B
-
Value change
-
+$217M
-
Put/Call ratio
-
0.97
-
Number of buys
-
125
-
Number of sells
-
-135
-
Price
-
$59.61
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2019
334 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2019.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.3M shares
of 66.6M outstanding shares and own 81.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.49M shares), BlackRock Inc. (4.28M shares), WELLINGTON MANAGEMENT GROUP LLP (3.05M shares), FMR LLC (2.35M shares), FEDERATED HERMES, INC. (1.46M shares), FRED ALGER MANAGEMENT, LLC (1.44M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.36M shares), STATE STREET CORP (1.33M shares), TimesSquare Capital Management, LLC (1.3M shares), and GILDER GAGNON HOWE & CO LLC (1.23M shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.